Insider Trading activities of Aerie Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aerie Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aerie Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Aerie Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AERI. The reporting company's CIK number is 1337553.
The total value of stock buying since 2005 is $12,137,673.
The total value of stock sales since 2005 is $166,487,790.
The total value of stock option exercises since 2005 is $1,054,276.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aerie Pharmaceuticals Inc (AERI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-02 0 $0 41,591 $1,939,491 58,167 $1,054,276
2016-10 0 $0 50,000 $2,017,000 0 $0
2016-07 250,000 $4,375,000 0 $0 0 $0
2015-08 3,646 $59,664 0 $0 0 $0
2015-04 0 $0 425,000 $14,297,905 0 $0
2015-02 1,000 $25,070 0 $0 0 $0
2015-01 0 $0 198,620 $6,173,871 0 $0
2014-12 0 $0 130,428 $3,934,549 0 $0
2014-11 0 $0 2,100,000 $54,561,000 0 $0
2014-07 0 $0 3,016,044 $73,581,062 0 $0
2014-05 1,854 $27,939 623,932 $9,982,912 0 $0
2013-10 1,049,000 $7,650,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aerie Pharmaceuticals Inc insiders (AERI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-02-15 Duyk Geoffrey M (Director) Sale 20,796 46.81 973,439
2017-02-14 Duyk Geoffrey M (Director) Sale 20,795 46.46 966,052
2017-02-14 Duyk Geoffrey M (Director) Option Ex 58,167 18.12 1,054,276
2016-10-06 Tananbaum James B. (10% Owner) Sale 50,000 40.34 2,017,000
2016-07-22 Tananbaum James B. (10% Owner) Buy 250,000 17.50 4,375,000
2015-08-28 Cagle Gerald D. (Director) Buy 2,000 16.60 33,200
2015-08-12 Cagle Gerald D. (Director) Buy 500 15.46 7,729
2015-08-10 Cagle Gerald D. (Director) Buy 1,146 16.35 18,735
2015-04-15 Mehra Anand (Director) Sale 294,298 33.45 9,843,973
2015-04-14 Mehra Anand (Director) Sale 130,702 34.08 4,453,932
2015-02-05 Cagle Gerald D. (Director) Buy 500 24.54 12,270
2015-02-04 Cagle Gerald D. (Director) Buy 500 25.60 12,800
2015-01-08 Wheeler Kurt (10% Owner) Sale 175,000 31.11 5,444,250
2015-01-05 Wheeler Kurt (10% Owner) Sale 23,620 30.89 729,621
2014-12-29 Wheeler Kurt (10% Owner) Sale 6,214 30.03 186,606
2014-12-26 Wheeler Kurt (10% Owner) Sale 74,510 30.05 2,239,025
2014-12-23 Wheeler Kurt (10% Owner) Sale 263 30.00 7,890
2014-12-22 Wheeler Kurt (10% Owner) Sale 49,441 30.36 1,501,028
2014-11-25 Mehra Anand Sale 800,000 26.00 20,800,000
2014-11-25 Coulter James G Sale 1,300,000 25.97 33,761,000
2014-07-10 Mehra Anand (10% Owner) Sale 8,022 25.81 207,031
2014-07-10 Powell Michael (10% Owner) Sale 8,022 25.81 207,031
2014-07-10 Coulter James G Sale 500,000 25.28 12,640,000
2014-07-09 Mehra Anand (10% Owner) Sale 1,000,000 24.00 24,001,000
2014-07-09 Powell Michael (10% Owner) Sale 1,000,000 24.00 24,001,000
2014-07-09 Coulter James G Sale 500,000 25.05 12,525,000
2014-05-22 Sofinnova Management Vii, L.l.c. (10% Owner) Sale 323,932 16.00 5,182,912
2014-05-22 Nohra Guy P (10% Owner) Sale 300,000 16.00 4,800,000
2014-05-16 Cagle Gerald D. (Director) Buy 1,854 15.07 27,939
2013-10-30 Levy Brian (Chief Medical Officer) Buy 6,000 10.00 60,000
2013-10-30 Rubino Richard J (Chief Financial Officer) Buy 10,000 10.00 100,000
2013-10-30 Mitro Thomas A (President and COO) Buy 5,000 10.00 50,000
2013-10-30 Anido Vicente Jr (Chief Executive Officer) Buy 28,000 10.00 280,000
2013-10-30 Nohra Guy P (10% Owner) Buy 110,000 10.00 1,100,000
2013-10-30 Coulter James G Buy 284,000 .00 0
2013-10-25 Sofinnova Management Vii, L.l.c. (10% Owner) Buy 285,000 10.00 2,850,000
2013-10-25 Wheeler Kurt (10% Owner) Buy 321,000 10.00 3,210,000

Insider trading activities including stock purchases, stock sales, and option exercises of AERI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aerie Pharmaceuticals Inc (symbol AERI, CIK number 1337553) see the Securities and Exchange Commission (SEC) website.